Skip to main content
Clinical Trials/NL-OMON55649
NL-OMON55649CompletedNot Applicable

INDICO AF - Atrial Fibrillation in patients with an implantable cardioverter defibrillator and coronary artery disease. - INDICO AF

Academisch Medisch Centrum0 sites50 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Age between 18 and 80 years
  • CAD, evident from a) previous myocardial infarction or b) revascularization
  • through PCI or CABG
  • LVEF<35%, quantified on MRI, with nuclear imaging or determined by
  • echocardiography
  • Willing and able to sign informed consent and to comply with the protocol and
  • with the follow-up
  • Life expectancy > 2 years

Exclusion Criteria

  • Unwilling to sign informed consent
  • Current atrial fibrillation
  • A history of atrial fibrillation not including postoperative atrial
  • fibrillation
  • Previous catheter or surgical ablation for atrial fibrillation
  • Current use or current indication of vitamin K antagonist or NOACs
  • Use of class 1 or 3 antiarrhythmic drugs for ventricular or supraventricular
  • arrhythmia ` other than AF
  • Prosthetic heart valves
  • Dilated or hypertrophic cardiomyopathy
  • Congenital heart disease for which surgical correction was performed
  • Inherited arrhythmia syndrome
  • Active malignant disease
  • Use of antracyclins in the history
  • Being pregnant or of child bearing potential
  • Life expectancy<2 years

Investigators

Similar Trials